Nutrición Hospitalaria 00806 / http://dx.doi.org/10.20960/nh.806
Resumen| PDF (ENGLISH)

Revisión

Probiotic: effectiveness nutrition in cancer treatment and prevention


Débora Mara Kich, Angélica Vincenzi, Fernanda Majolo, Claucia Fernanda Volken De Souza, Márcia Inês Goettert

Logo Descargas   Número de descargas: 18812      Logo Visitas   Número de visitas: 15127      Citas   Citas: 12

Compártelo:


Among the neoplasias, colorectal cancer is one of the leading causes of cancer death in men and women. The increasing incidence of this type of cancer is due to the increase in the population’s life expectancy, by the increase in chronic inflammatory bowel diseases, primarily ulcerative colitis and Crohn’s disease, and the change in eating habits. The American Cancer Society (2011) shows that diet might be responsible for approximately 30% of cancer cases in developed countries, moreover when considering only colorectal cancer, the number can reach 30% to 50%. Probiotics are effective in the prevention and treatment of many bowel diseases as inflammatory bowel disease (IBD), diarrhea, irritable bowel syndrome, gluten intolerance, gastroenteritis, Helicobacter pyloriinfection, and colon cancer. Classical examples are strains from the Lactobacillus, and Bifidobacteriumgenus that have probiotic proprieties with a potential use in the prophylaxis, as well as in the treatment of a variety of gastrointestinal tract disorders. Researchers are focusing on extremely important studies regarding the possibility of using probiotics to promote a balanced microbiota composition, and a sufficient immunological surveillance system as a way to prevent cancer. Considering the fact that the human intestines host 100 trillion bacteria, including more than 1,000 species, there is still need to perform more in depth investigations in order to find probiotics with potential to prevent, and treat cancerous diseases, adding a very promising effect to this already successful panorama. This revision aims to conduct a review of the most recent studies correlating probiotics and its cancer preventing and treatment potential.

Palabras Clave: Colorectal cancer. Inflammatory bowel disease. Probiotics. Intestinal microbiota. Immune system.



Fan, Xiaoyan, Jin, Yuelei, Chen, Guang, Ma, Xueqiang, Zhang, Lixia (2021) Gut Microbiota Dysbiosis Drives the Development of Colorectal Cancer. Digestion
Armstrong, Heather, Bording-Jorgensen, Michael, Wine, Eytan (2021) The Multifaceted Roles of Diet, Microbes, and Metabolites in Cancer. Cancers
Roberto, Michela, Carconi, Catia, Cerreti, Micaela, Schipilliti, Francesca Matilde, Botticelli, Andrea, Mazzuca, Federica, Marchetti, Paolo (2021) The Challenge of ICIs Resistance in Solid Tumours: Could Microbiota and Its Diversity Be Our Secret Weapon?. Frontiers in Immunology
Wang, Huijuan, Chen, Ke, Ning, Mengge, Wang, Xin, Wang, Zhouli, Yue, Yuan, Yuan, Yahong, Yue, Tianli (2023) Intake of Pro‐ and/or Prebiotics as a Promising Approach for Prevention and Treatment of Colorectal Cancer. Molecular Nutrition & Food Research
Sadrekarimi, Hourieh, Gardanova, Zhanna R., Bakhshesh, Morteza, Ebrahimzadeh, Farnoosh, Yaseri, Amirhossein Fakhre, Thangavelu, Lakshmi, Hasanpoor, Zahra, Zadeh, Firoozeh Abolhasani, Kahrizi, Mohammad Saeed (2022) Emerging role of human microbiome in cancer development and response to therapy: special focus on intestinal microflora. Journal of Translational Medicine
Huang, Roujie, Wu, Fei, Zhou, Qian, Wei, Wei, Yue, Juan, Xiao, Bo, Luo, Zhaohui (2022) Lactobacillus and intestinal diseases: Mechanisms of action and clinical applications. Microbiological Research
Rocha-Ramírez, Luz María, Hernández-Chiñas, Ulises, Moreno-Guerrero, Silvia Selene, Ramírez-Pacheco, Arturo, Eslava, Carlos A. (2021) Probiotic Properties and Immunomodulatory Activity of Lactobacillus Strains Isolated from Dairy Products. Microorganisms
Salehi, Ali, Naserzadeh, Parvaneh, Tarighi, Parastoo, Afjeh-Dana, Elham, Akhshik, Masoud, Jafari, Amir, Mackvandi, Pooyan, Ashtari, Behnaz, Mozafari, Masoud (2023) Fabrication of a microfluidic device for probiotic drug's dosage screening: Precision Medicine for Breast Cancer Treatment. Translational Oncology
Haneda, Ryoma, Hiramatsu, Yoshihiro, Kawata, Sanshiro, Soneda, Wataru, Booka, Eisuke, Murakami, Tomohiro, Matsumoto, Tomohiro, Morita, Yoshifumi, Kikuchi, Hirotoshi, Takeuchi, Hiroya (2024) Clinical impact of diarrhea during enteral feeding after esophagectomy. International Journal of Clinical Oncology
Aguirre-Portolés, Cristina, Fernández, Lara, Ramírez de Molina, Ana (2017) Precision Nutrition for Targeting Lipid Metabolism in Colorectal Cancer. Nutrients
Davoodvandi, Amirhossein, Marzban, Havva, Goleij, Pouya, Sahebkar, Amirhossein, Morshedi, Korosh, Rezaei, Samaneh, Mahjoubin-Tehran, Maryam, Tarrahimofrad, Hossein, Hamblin, Michael R., Mirzaei, Hamed (2021) Effects of therapeutic probiotics on modulation of microRNAs. Cell Communication and Signaling

Artículos más populares

Carta Editor: Revisión sistemática frente a “scoping review”: guía para una elección informada en las investigaciones

Publicado: 2024-05-19

Revisión: La obesidad y su relación con el cáncer

El objeto del presente estudio es investigar cómo...

Publicado: 2024-07-29

Una cookie o galleta informática es un pequeño archivo de información que se guarda en su navegador cada vez que visita nuestra página web. La utilidad de las cookies es guardar el historial de su actividad en nuestra página web, de manera que, cuando la visite nuevamente, ésta pueda identificarle y configurar el contenido de la misma en base a sus hábitos de navegación, identidad y preferencias. Las cookies pueden ser aceptadas, rechazadas, bloqueadas y borradas, según desee. Ello podrá hacerlo mediante las opciones disponibles en la presente ventana o a través de la configuración de su navegador, según el caso. En caso de que rechace las cookies no podremos asegurarle el correcto funcionamiento de las distintas funcionalidades de nuestra página web. Más información en el apartado “POLÍTICA DE COOKIES” de nuestra página web.